Tonghua Dongbao Pharmaceutical Co Ltd
Tonghua Dongbao Pharmaceutical Co., Ltd. researches, develops, produces, and markets pharmaceuticals in China. It offers human insulin injections; insulin glargine injections; insulin aspart injections; liraglutide injections; and proprietary Chinese medicine. The company also provides insulin pen and pen needles; and chronic disease management platform, a diabetes management platform for drug treatment, blood glucose monitoring, and patient education. In addition, it offers chemical drugs, such as repaglinide, sitagliptin phosphate, and metformin hydrochloride tablets. Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is headquartered in Tonghua, China.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of 600867-SS would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (1994) — listing | $236,612 5.0× | $335,905 4.9× |
| Year 6 (1999) | $169,612 4.2× | $242,045 4.1× |
| Year 11 (2004) | $114,973 3.5× | $165,266 3.4× |
| Year 16 (2009) | $38,992 1.5× | $57,424 1.5× |
| Year 21 (2014) | $15,659 0.9× | $23,152 0.9× |
| Year 26 (2019) | $9,398 0.9× | $13,885 0.9× |
| Year 31 (2024) | $3,517 1.0× | $5,265 1.0× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Popular scenarios with 600867
For illustration only — not investment advice. Past performance is not indicative of future results.